Pharmacovigilance for evaluating adverse drug reactions: value, organization, and methods
- 1 December 2006
- journal article
- review article
- Published by Elsevier BV in Joint Bone Spine
- Vol. 73 (6), 629-632
- https://doi.org/10.1016/j.jbspin.2006.09.002
Abstract
No abstract availableThis publication has 6 references indexed in Scilit:
- Using a capture–recapture method to assess the frequency of adverse drug reactions in a French university hospitalBritish Journal of Clinical Pharmacology, 2006
- Under-Reporting of Adverse Drug ReactionsDrug Safety, 2006
- A propos d’une campagne de vaccination contre la méningite C dans les Hautes-Pyrénées : réflexions de pharmacovigilancePublished by Elsevier BV ,2005
- Upper gastrointestinal adverse drug reactions and cyclo-oxygenase-2 inhibitors (celecoxib and rofecoxib): a case/non-case study from the French Pharmacovigilance DatabaseEuropean Journal of Clinical Pharmacology, 2004
- Detection and incidence of muscular adverse drug reactions: a prospective analysis from laboratory signalsEuropean Journal of Clinical Pharmacology, 2004
- Mechanism of action of adverse drug reactions: an overviewPharmacoepidemiology and Drug Safety, 1997